JP Morgan Chase’s abrdn Healthcare Investors HQH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.3K | Buy |
365
+12
| +3% | +$227 | ﹤0.01% | 6845 |
|
|
2025
Q4 | $6.69K | Hold |
353
| – | – | ﹤0.01% | 6756 |
|
|
2025
Q3 | $6.52K | Hold |
353
| – | – | ﹤0.01% | 6724 |
|
|
2025
Q2 | $5.47K | Sell |
353
-11
| -3% | -$170 | ﹤0.01% | 6407 |
|
|
2025
Q1 | $5.91K | Sell |
364
-170
| -32% | -$2.92K | ﹤0.01% | 6406 |
|
|
2024
Q4 | $8.57K | Buy |
534
+175
| +49% | +$3.1K | ﹤0.01% | 6414 |
|
|
2024
Q3 | $6.68K | Buy |
359
+1
| +0.3% | +$19 | ﹤0.01% | 6436 |
|
|
2024
Q2 | $6.25K | Buy |
358
+5
| +1% | +$83 | ﹤0.01% | 6337 |
|
|
2024
Q1 | $5.95K | Sell |
353
-11,705
| -97% | -$199K | ﹤0.01% | 6419 |
|
|
2023
Q4 | $200K | Buy |
12,058
+11,781
| +4,253% | +$181K | ﹤0.01% | 5389 |
|
|
2023
Q3 | $4.31K | Sell |
277
-3,845
| -93% | -$64.1K | ﹤0.01% | 6396 |
|
|
2023
Q2 | $70.3K | Sell |
4,122
-20,132
| -83% | -$349K | ﹤0.01% | 5620 |
|
|
2023
Q1 | $428K | Sell |
24,254
-14,588
| -38% | -$265K | ﹤0.01% | 4602 |
|
|
2022
Q4 | $699K | Buy |
38,842
+38,235
| +6,299% | +$708K | ﹤0.01% | 4295 |
|
|
2022
Q3 | $10K | Buy |
+607
| New | +$11.6K | ﹤0.01% | 5962 |
|
|
2022
Q2 | – | Sell |
-18
| Closed | – | – | 6645 |
|
|
2022
Q1 | $0 | Buy |
18
+8
| +80% | +$170 | ﹤0.01% | 6778 |
|
|
2021
Q4 | $0 | Buy |
10
+2
| +25% | +$50 | ﹤0.01% | 6780 |
|
|
2021
Q3 | $0 | Buy |
8
+2
| +33% | +$53 | ﹤0.01% | 6625 |
|
|
2021
Q2 | $0 | Buy |
6
+3
| +100% | +$74 | ﹤0.01% | 6447 |
|
|
2021
Q1 | $0 | Sell |
3
-1
| -25% | -$24 | ﹤0.01% | 6182 |
|
|
2020
Q4 | $0 | Sell |
4
-1
| -20% | -$22 | ﹤0.01% | 5752 |
|
|
2020
Q3 | $0 | Buy |
5
+1
| +25% | +$21 | ﹤0.01% | 5592 |
|
|
2020
Q2 | $0 | Buy |
4
+1
| +33% | +$20 | ﹤0.01% | 5513 |
|
|
2020
Q1 | $0 | Sell |
3
-1
| -25% | -$20 | ﹤0.01% | 5469 |
|
|
2019
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 5727 |
|
|
2019
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 5831 |
|
|
2019
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 5856 |
|
|
2019
Q1 | $0 | Buy |
+4
| New | +$82 | ﹤0.01% | 5892 |
|
|
2017
Q2 | – | Sell |
-46
| Closed | -$1K | – | 5066 |
|
|
2017
Q1 | $1K | Buy |
+46
| New | +$1.08K | ﹤0.01% | 4987 |
|
|
2014
Q4 | – | Sell |
-35,071
| Closed | -$974K | – | 4275 |
|
|
2014
Q3 | $974K | Buy |
+35,071
| New | +$950K | ﹤0.01% | 3350 |
|
Other funds holding HQH
PCM
AAM
NIM
ZCP
JP Morgan Chase's HQH Position: Q1 2026 in Review
JP Morgan Chase increased its abrdn Healthcare Investors (HQH) stake by 3.4% in Q1 2026, buying an estimated $227 and bringing the position to 365 shares worth $6.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6845.
JP Morgan Chase first reported a position in HQH in Q3 2014 and has held it in 30 quarters since. The position peaked at $974K in Q3 2014. 128 funds tracked by Wall St. Rank hold HQH as of Q1 2026.
- JP Morgan Chase held 365 shares of abrdn Healthcare Investors worth $6.3K as of Q1 2026.
- JP Morgan Chase bought 12 abrdn Healthcare Investors shares in Q1 2026, an estimated $227.
- abrdn Healthcare Investors made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6845 holding.
- JP Morgan Chase first reported a position in abrdn Healthcare Investors in Q3 2014 and has held it in 30 quarters since.
- JP Morgan Chase's abrdn Healthcare Investors position peaked at $974K in Q3 2014.
- 128 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.